序号 |
标题 |
次数 |
作者 |
发布时间 |
76996 |
m-PEG6-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-88-9) |
130 |
WYQ |
2024-12-16 |
76997 |
Butyne-DOTA-tris(t-butyl ester),CAS: 2125661-54-1 |
153 |
h |
2024-12-16 |
76998 |
pAAV-PEG3-sTRAIL质粒 |
94 |
kx |
2024-12-16 |
76999 |
m-PEG4-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-89-0) |
116 |
WYQ |
2024-12-16 |
77000 |
DOTA-PEG4-alkyne,CAS:2080307-47-5 |
79 |
h |
2024-12-16 |
77001 |
m-PEG8-(CH2)12-phosphonic acid(CAS号:2093153-86-5) |
73 |
WYQ |
2024-12-16 |
77002 |
DOTA-NHS-ester,CAS:170908-81-3 |
63 |
h |
2024-12-16 |
77003 |
99Tcm-3PEG4-RGD |
108 |
kx |
2024-12-16 |
77004 |
Azido-PEG5-CH2CO2-t-Bu(CAS号:1448451-72-6) |
67 |
WYQ |
2024-12-16 |
77005 |
DOTA螯合剂DOTA-4AMP,CAS:254444-71-8 |
82 |
h |
2024-12-16 |
77006 |
Azido-PEG4-CH2CO2-t-Bu(CAS号:864681-04-9) |
69 |
WYQ |
2024-12-16 |
77007 |
alkoxyamine-PEG4-biotin ,烷氧基胺-四聚乙二醇-生物素 |
201 |
kx |
2024-12-16 |
77008 |
DOTA-CXCR4-L,DOTA-CXCR4靶向肽 |
111 |
h |
2024-12-16 |
77009 |
DOTA-Tetrazine,DOTA-四嗪 |
76 |
h |
2024-12-16 |
77010 |
Ag~(TS)-S(CH2)_(n-1)CH3// Ga2O3/EGaIn junctions,烷基链定制 |
141 |
wyh |
2024-12-16 |
77011 |
CMP-SA-PEG4-biotin的主要结构组成及功能 |
154 |
kx |
2024-12-16 |
77012 |
DOTA-Tetrazine,DOTA-四嗪 |
88 |
h |
2024-12-16 |
77013 |
Au25(SCH2CH2Ph)18,烷基链定制 |
104 |
wyh |
2024-12-16 |
77014 |
18F-AlF-NOTA-PEG4-ZD2 , 18F-AlF-1,4,7-三氮杂环壬烷-1,4,7-三乙酸-(聚乙二醇)4-ZD2 |
102 |
kx |
2024-12-16 |
77015 |
亲脂性硼剂K[nido-7-CH3(CH2)15-7,8-C2B9H11,烷基链定制 |
77 |
wyh |
2024-12-16 |
77016 |
Azido-PEG3-CH2CO2-t-Bu(CAS号:172531-36-1) |
105 |
WYQ |
2024-12-16 |
77017 |
mPEG113-b-P(MTC-Cholx-co-TMCy)x+y |
104 |
kx |
2024-12-16 |
77018 |
亲脂性硼剂K[nido-7-CH3(CH2)15-7,8-C2B9H11,烷基链定制 |
115 |
wyh |
2024-12-16 |
77019 |
m-PEG6-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-88-9) |
84 |
WYQ |
2024-12-16 |
77020 |
DTPA(Gd)-PEG8-(FY)3 , DTPA(Gd)-聚乙二醇8-(FY)3 |
97 |
kx |
2024-12-16 |
77021 |
靶向CD45的抗体药物偶联物 |
119 |
kx |
2024-12-16 |
77022 |
m-PEG4-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-89-0) |
78 |
WYQ |
2024-12-16 |
77023 |
抗体偶联药物的药物连接子MCMMAF |
106 |
kx |
2024-12-16 |
77024 |
m-PEG8-(CH2)12-phosphonic acid(CAS号:2093153-86-5) |
66 |
WYQ |
2024-12-16 |
77025 |
全氟十四烷酸(PF;CF3(CF2)12COOH),烷基链定制 |
165 |
wyh |
2024-12-16 |
77026 |
靶向CD45的抗体药物偶联物 |
120 |
kx |
2024-12-16 |
77027 |
CH3(CH2)7COOH-CH3(CH2)7COO钠,烷基链定制 |
105 |
wyh |
2024-12-16 |
77028 |
HS(CH2)17CH3 ,十八硫醇,烷基链定制 |
151 |
wyh |
2024-12-16 |
77029 |
Fmoc-Val-Cit-PABC-Cn |
103 |
kx |
2024-12-16 |
77030 |
Mc-Val-Cit-PABOH ,组织蛋白酶B可切割 |
131 |
kx |
2024-12-16 |
77031 |
m-PEG6-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-88-9) |
114 |
WYQ |
2024-12-16 |
77032 |
抗体偶联药物连接子Mc-Val-Cit-PABC-PNP |
113 |
kx |
2024-12-16 |
77033 |
NHS-d-PEG24-biotin |
138 |
kx |
2024-12-16 |
77034 |
β-agarase-BTPEG24-SA@MNPs , β-琼胶酶-生物素/链霉亲和素修饰的磁性纳米粒子 |
99 |
kx |
2024-12-16 |
77035 |
m-PEG4-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-89-0) |
75 |
WYQ |
2024-12-16 |
77036 |
KYE28-PEG48 |
125 |
kx |
2024-12-16 |
77037 |
[(18)F]F-PEG(6)-IPQA PET示踪剂 |
122 |
kx |
2024-12-16 |
77038 |
m-PEG8-(CH2)12-phosphonic acid(CAS号:2093153-86-5) |
88 |
WYQ |
2024-12-16 |
77039 |
HS-(CH2)17-CH3,1-十八硫醇,烷基链定制 |
89 |
wyh |
2024-12-16 |
77040 |
MePEG17-b-PCL5 ,甲氧基聚乙二醇-嵌段-聚己内酯 |
89 |
kx |
2024-12-16 |